Ticker: PCSA

Company: Processa Pharmaceuticals, Inc.

Person: Patrick Lin, officer

Transaction date: April 15, 2026

Reporting date: April 17, 2026

Average share price: 2.97

Bought 1369.0 shares for 4065.93